GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
70.32
+0.81 (1.17%)
Jun 11, 2025, 4:00 PM - Market closed
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.01 billion as of June 12, 2025. Its market cap has increased by 289.08% in one year.
Market Cap
2.01B
Enterprise Value
1.96B
1-Year Change
289.08%
Ranking
Category
Stock Price
$70.32
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.01B, a decrease of -88.79%. That is a compound annual growth rate of -37.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 1.98B | -6.07% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.62B |
| Johnson & Johnson | 375.11B |
| AbbVie | 334.91B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.14B |
| Abbott Laboratories | 232.72B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.45B |